Human DNA topoisomerase I: relaxation, roles, and damage control.

作者: John B. Leppard , James J. Champoux

DOI: 10.1007/S00412-005-0345-5

关键词: TopoisomeraseCell biologyBiochemistryDNA damageEukaryotic DNA replicationBiologyDNA polymerase IIDNA replicationDNA ligaseDNA supercoilDNA clamp

摘要: Human DNA topoisomerase I is an essential enzyme involved in resolving the torsional stress associated with replication, transcription, and chromatin condensation. The catalytic cycle of consists cleavage to form a covalent enzyme–DNA intermediate, relaxation, finally, religation phosphate backbone restore continuity DNA. Structure/function studies have elucidated flexible that relaxes through coordinated, controlled movements distinct domains. cellular roles are apparent throughout nucleus, but concentration processes acting on ribosomal results accumulation nucleolus. Although activity required these processes, can also deleterious effect cells. In event final step reaction prevented, I–DNA intermediate becomes toxic lesion must be repaired. complexities relaxation reaction, roles, pathways exist repair I-mediated damage highlight importance continued study this enzyme.

参考文章(91)
K. R. Madden, L. Stewart, J. J. Champoux, Preferential binding of human topoisomerase I to superhelical DNA. The EMBO Journal. ,vol. 14, pp. 5399- 5409 ,(1995) , 10.1002/J.1460-2075.1995.TB00224.X
M.T. Muller, W.P. Pfund, V.B. Mehta, D.K. Trask, Eukaryotic type I topoisomerase is enriched in the nucleolus and catalytically active on ribosomal DNA. The EMBO Journal. ,vol. 4, pp. 1237- 1243 ,(1985) , 10.1002/J.1460-2075.1985.TB03766.X
Nicholas R. Cozzarelli, James C. Wang, DNA topology and its biological effects Cold Spring Harbor Laboratory Press. ,(1990)
Mary K. Danks, Raquel C. Marion, David O. Whipple, Katherine E. Garrett, Subcellular Redistribution of DNA Topoisomerase I in Anaplastic Astrocytoma Cells Treated with Topotecan Cancer Research. ,vol. 56, pp. 1664- 1673 ,(1996)
J Alsner, J.Q. Svejstrup, E Kjeldsen, B.S. Sørensen, O Westergaard, Identification of an N-terminal domain of eukaryotic DNA topoisomerase I dispensable for catalytic activity but essential for in vivo function. Journal of Biological Chemistry. ,vol. 267, pp. 12408- 12411 ,(1992) , 10.1016/S0021-9258(18)42288-0
Jeffrey G Supko, Rocio Garcia-Carbonero, Current Perspectives on the Clinical Experience, Pharmacology, and Continued Development of the Camptothecins Clinical Cancer Research. ,vol. 8, pp. 641- 661 ,(2002)
S G Morham, K D Kluckman, N Voulomanos, O Smithies, Targeted disruption of the mouse topoisomerase I gene by camptothecin selection Molecular and Cellular Biology. ,vol. 16, pp. 6804- 6809 ,(1996) , 10.1128/MCB.16.12.6804
Fred E. Indig, Jean-Philippe Laine, Vilhelm A. Bohr, Cayetano von Kobbe, Patricia L. Opresko, Jeanine A. Harrigan, Werner protein stimulates topoisomerase I DNA relaxation activity. Cancer Research. ,vol. 63, pp. 7136- 7146 ,(2003)
B. L. Staker, K. Hjerrild, M. D. Feese, C. A. Behnke, A. B. Burgin, L. Stewart, The mechanism of topoisomerase I poisoning by a camptothecin analog Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 15387- 15392 ,(2002) , 10.1073/PNAS.242259599